Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble Co's Current Accrued Expense for the quarter that ended in Jun. 2026 was zł16,598 Mil.
Procter & Gamble Co's quarterly Current Accrued Expense
declined
from Dec. 2025 (zł39,097 Mil) to Mar. 2026 (zł37,483 Mil) and
declined
from Mar. 2026 (zł37,483 Mil) to Jun. 2026 (zł16,598 Mil).
Procter & Gamble Co's annual Current Accrued Expense
declined
from Jun. 2024 (zł16,643 Mil) to Jun. 2025 (zł15,485 Mil) but then
increased
from Jun. 2025 (zł15,485 Mil) to Jun. 2026 (zł16,598 Mil).
Procter & Gamble Co Current Accrued Expense Related Terms
Procter & Gamble Co Current Accrued Expense Historical Data
* Premium members only.
The historical data trend for Procter & Gamble Co's Current Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Co Current Accrued Expense Calculation
Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.
What does a Current Accrued Expense of zł16,598 Mil mean?
Procter & Gamble Co (WAR:PCGL) has a Current Accrued Expense of zł16,598 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Procter & Gamble Co and its competitors.
Is Procter & Gamble Co's Current Accrued Expense too high?
Procter & Gamble Co's current Current Accrued Expense is zł16,598 Mil. Overall, Procter & Gamble Co has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Co's Current Accrued Expense compare to CL and KVUE?
Procter & Gamble Co's Current Accrued Expense of zł16,598 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Consumer Packaged Goods company?
A good Current Accrued Expense depends on the Consumer Packaged Goods industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Procter & Gamble Co and its competitors. Procter & Gamble Co's current Current Accrued Expense is zł16,598 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Co stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Co (WAR:PCGL) is currently considered Modestly Undervalued. The stock's GF Value™ is zł635.28, compared to a current price of zł551.60 — trading 13.2% below its estimated fair value. The current Current Accrued Expense is zł16,598 Mil. Procter & Gamble Co's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Procter & Gamble Co (WAR:PCGL), the current Current Accrued Expense is zł16,598 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Co (WAR:PCGL) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Co stock appears to be undervalued.
The current stock price of zł551.60 is trading 13.2% below its estimated GF Value™ of zł635.28.
GuruFocus considers Procter & Gamble Co to be Modestly Undervalued.
Key valuation signals for WAR:PCGL:
Current Accrued Expense: zł16,598 Mil
GF Value™: zł635.28 vs. price of zł551.60 (13.2% below fair value)
No single metric tells the full story. See the WAR:PCGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
74GF Score
Get the complete analysis for WAR:PCGL
Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCGL has been successfully added to your 
